HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniela Salvemini Selected Research

G-Protein-Coupled Receptors (Receptors, G Protein Coupled)

1/202412-(S)-Hydroxyeicosatetraenoic Acid and GPR31 Signaling in Spinal Cord in Neuropathic Pain.
11/2022Activation of GPR183 by 7α,25-Dihydroxycholesterol Induces Behavioral Hypersensitivity through Mitogen-Activated Protein Kinase and Nuclear Factor-κB.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniela Salvemini Research Topics

Disease

57Pain (Aches)
01/2024 - 06/2004
41Neuralgia (Stump Neuralgia)
01/2024 - 12/2011
33Hyperalgesia
11/2022 - 06/2004
23Chronic Pain
10/2021 - 11/2007
21Inflammation (Inflammations)
01/2023 - 05/2002
13Hypersensitivity (Allergy)
01/2024 - 09/2008
12Peripheral Nervous System Diseases (PNS Diseases)
01/2022 - 05/2012
12Neoplasms (Cancer)
01/2022 - 06/2003
9Shock
02/2009 - 11/2002
5Neuroinflammatory Diseases
01/2023 - 07/2013
5Multiple Sclerosis
01/2023 - 07/2014
5Body Weight (Weight, Body)
01/2022 - 06/2003
5Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 05/2012
4Asthma (Bronchial Asthma)
01/2023 - 08/2005
4Cognitive Dysfunction
01/2022 - 01/2018
4Edema (Dropsy)
01/2013 - 06/2004
4Hypotension (Low Blood Pressure)
06/2011 - 01/2003
4Ischemia
10/2008 - 06/2002
4Reperfusion Injury
10/2008 - 07/2002
3Heart Failure
10/2023 - 07/2002
3Atherosclerosis
07/2019 - 07/2003
3Wounds and Injuries (Trauma)
01/2018 - 04/2011
3Necrosis
09/2004 - 05/2002
3Septic Shock (Toxic Shock Syndrome)
01/2003 - 11/2002
2Breast Neoplasms (Breast Cancer)
11/2023 - 11/2016
2Fibrosis (Cirrhosis)
11/2022 - 01/2020
2Migraine Disorders (Migraine)
10/2021 - 01/2020
2Headache (Headaches)
10/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

33Peroxynitrous Acid (Peroxynitrite)IBA
10/2021 - 06/2002
30Superoxides (Superoxide)IBA
12/2016 - 05/2002
24Superoxide DismutaseIBA
12/2020 - 06/2002
19Analgesics (Analgesic Drugs)IBA
11/2023 - 11/2007
18Opioid Analgesics (Opioids)IBA
01/2024 - 08/2012
16Purinergic P1 Receptors (Adenosine Receptor)IBA
07/2021 - 05/2012
15EnzymesIBA
01/2020 - 06/2002
14Morphine (MS Contin)FDA LinkGeneric
11/2023 - 04/2009
12CeramidesIBA
09/2017 - 02/2008
11Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2023 - 06/2002
11CytokinesIBA
11/2022 - 01/2003
11Reactive Oxygen Species (Oxygen Radicals)IBA
12/2020 - 06/2002
11imisopasem manganeseIBA
05/2008 - 05/2002
10Sphingosine-1-Phosphate ReceptorsIBA
11/2022 - 03/2011
10sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2022 - 03/2011
10Adenosine (Adenocard)FDA LinkGeneric
01/2021 - 01/2003
10CarrageenanIBA
01/2020 - 06/2004
10Opiate AlkaloidsIBA
07/2013 - 11/2007
9Fingolimod Hydrochloride (FTY720)FDA Link
01/2022 - 01/2013
7Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 05/2012
7Paclitaxel (Taxol)FDA LinkGeneric
09/2021 - 05/2012
7Narcotics (Narcotic Analgesics)IBA
07/2021 - 06/2004
7SphingolipidsIBA
11/2020 - 08/2011
73-nitrotyrosineIBA
08/2012 - 08/2002
6N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
07/2021 - 05/2012
6PorphyrinsIBA
12/2020 - 04/2010
5Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2013
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2021 - 05/2002
5ProstaglandinsIBA
12/2020 - 02/2008
5AntioxidantsIBA
12/2020 - 05/2004
5MRS5698IBA
01/2020 - 12/2014
5AnionsIBA
01/2015 - 05/2002
5M40401IBA
10/2004 - 01/2003
4LigandsIBA
11/2022 - 06/2004
4Adenosine A3 ReceptorIBA
11/2022 - 01/2015
4Interleukin-10 (Interleukin 10)IBA
01/2021 - 02/2015
4Bortezomib (Velcade)FDA Link
01/2020 - 05/2012
4Oxygen (Dioxygen)IBA
12/2016 - 01/2003
4NADPH Oxidases (NAD(P)H oxidase)IBA
12/2014 - 07/2003
4Oxidants (Oxidizing Agents)IBA
08/2012 - 06/2002
3AcidsIBA
01/2024 - 04/2010
3ProdrugsIBA
01/2023 - 01/2020
3Transcription Factors (Transcription Factor)IBA
11/2022 - 08/2004
3Adenosine KinaseIBA
11/2022 - 01/2015
3InflammasomesIBA
11/2022 - 11/2020
3NLR ProteinsIBA
11/2022 - 01/2020
3Therapeutic UsesIBA
01/2022 - 05/2004
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2003
3Free RadicalsIBA
09/2021 - 06/2003
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2020 - 06/2004
3OvalbuminIBA
10/2020 - 08/2005
3Purinergic P1 Receptor AgonistsIBA
01/2017 - 12/2014
3NitrogenIBA
12/2016 - 10/2010
3N-Methylaspartate (NMDA)IBA
01/2013 - 05/2002
3Interleukin-2 (IL2)IBA
06/2011 - 06/2003
3dihydroceramide desaturaseIBA
02/2009 - 02/2008
3Ligases (Synthetase)IBA
11/2002 - 06/2002
2Mitogen-Activated Protein KinasesIBA
01/2024 - 11/2022
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2024 - 11/2022
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
11/2022 - 11/2020
2SEW2871IBA
11/2022 - 01/2013
2Amino Acid Transport System X-AG (Glutamate Transporter)IBA
09/2021 - 01/2013
2Peptides (Polypeptides)IBA
01/2021 - 11/2020
2Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 12/2014
2Reactive Nitrogen SpeciesIBA
12/2020 - 11/2016
2manganese(III)-tetrakis(4-benzoic acid)porphyrinIBA
12/2020 - 01/2009
2Dinoprostone (PGE2)FDA Link
12/2020 - 08/2011

Therapy/Procedure

24Therapeutics
01/2024 - 05/2004
15Drug Therapy (Chemotherapy)
01/2022 - 05/2012
4Spinal Injections
01/2024 - 01/2013
3Intraperitoneal Injections
11/2020 - 09/2004
3Analgesia
12/2016 - 09/2008